Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design.

Authors
Type
Published Article
Journal
Clinical breast cancer
Publication Date
Volume
9
Issue
1
Pages
29–33
Identifiers
DOI: 10.3816/CBC.2009.n.005
PMID: 19299237
Source
Medline
License
Unknown

Abstract

Despite the poorer overall prognosis of patients with triple-negative disease, there remains considerable heterogeneity in individual outcomes. Many women with recurrent triple-negative disease will progress quickly on first-, second-, and third-line palliative treatment. Future clinical trials in this population must take into account their shorter time to progression when determining optimal trial design.

Statistics

Seen <100 times